Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eiger BioPharmaceuticals Stock (NASDAQ:EIGR), Quotes and News Summary
Eiger BioPharmaceuticals Stock (NASDAQ: EIGR) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range0.960 - 10.021 | Open / Close- / - | Float / Outstanding36.568M / 44.074M |
| Vol / Avg.2.252K / 998.529K | Mkt Cap94.760M | P/E- | 50d Avg. Price2.030 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float36.568M | EPS-2.400 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.520 | -0.620 | -0.1000 | ||||
| REV | 4.270M | 4.024M | -246.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Eiger BioPharmaceuticals (EIGR) stock?
You can purchase shares of Eiger BioPharmaceuticals (NASDAQ: EIGR) through any online brokerage.
Who are Eiger BioPharmaceuticals's (EIGR) competitors?
Other companies in Eiger BioPharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Fortress Biotech (NASDAQ:FBIO), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS) and Aligos Therapeutics (NASDAQ:ALGS).
What is the target price for Eiger BioPharmaceuticals (EIGR) stock?
The latest price target for Eiger BioPharmaceuticals (NASDAQ: EIGR) was reported by BTIG on Wednesday, September 7, 2022. The analyst firm set a price target for 48.00 expecting EIGR to rise to within 12 months (a possible 2132.56% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Eiger BioPharmaceuticals (EIGR)?
The stock price for Eiger BioPharmaceuticals (NASDAQ: EIGR) is $2.15 last updated February 2, 2023 at 9:00 PM UTC.
Does Eiger BioPharmaceuticals (EIGR) pay a dividend?
There are no upcoming dividends for Eiger BioPharmaceuticals.
When is Eiger BioPharmaceuticals (NASDAQ:EIGR) reporting earnings?
Eiger BioPharmaceuticals’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Eiger BioPharmaceuticals (EIGR) going to split?
There is no upcoming split for Eiger BioPharmaceuticals.
What sector and industry does Eiger BioPharmaceuticals (EIGR) operate in?
Eiger BioPharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.